Company News

BUZZ-U.S. STOCKS ON THE MOVE-Snap, Cidara Therapeutics, Aridis Pharmaceuticals

* Eikon search string for individual stock moves:

* The Day Ahead newsletter:

* The Morning News Call newsletter:

U.S. stock index futures fell on Tuesday as Washington’s new round of tariffs on some Chinese goods kicked in and after a report that officials from both sides were struggling to decide on the schedule for a meeting this month. At 8:17 ET, Dow e-minis were down 0.86% at 26,179. S&P 500 e-minis were down 0.74% at 2,903.25, while Nasdaq 100 e-minis were down 0.82% at 7,628. The top three NYSE percentage gainers premarket: ** Key Energy Services Inc, up 6.8% ** Autozone Inc, up 6.4% ** Owens & Minor Inc, up 6.3% The top three NYSE percentage losers premarket: ** Intelsat SA, down 10.5% ** Sasol Ltd, down 8.5% ** ProPetro Holding Corp, down 6.1% The top two Nasdaq percentage gainers premarket: ** Cidara Therapeutics Inc, up 66.7% ** Synthesis Energy Systems Inc, up 23.0% The top three Nasdaq percentage losers premarket: ** CIM Commercial Trust Corp, down 57.7% ** Aridis Pharmaceuticals Inc, down 0% ** TDH Holdings Inc, down 17.8% ** Snap Inc: up 1.7% premarket BUZZ-Snap’s game is strong; Evercore upgrades ** Cidara Therapeutics Inc: up 66.7% premarket BUZZ-Cidara soars on pact with Mundipharma to develop, sell Rezafungin ** Medicines Co: up 13.5% premarket BUZZ-Medicines Co: Jumps on full late-stage data for cholesterol drug ** Eldorado Gold Corp: up 5.7% premarket BUZZ-Eldorado Gold: Rises on optimism around Greece project permits ** Conn’s Inc: up 13.6% premarket BUZZ-Conn’s: Builds on Q2 results beat ** MAM Software Group Inc: up 12.5% premarket BUZZ-MAM Software set for best day in 3 years on takeover offer ** Aridis Pharmaceuticals Inc: down 27.1% premarket BUZZ-Aridis Pharmaceuticals: Falls after flu drug flunks mid-stage study (Compiled by Praveen Paramasivam in Bengaluru)